Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
45.36
+1.54 (3.51%)
Nov 4, 2024, 12:59 PM EST - Market open

Vera Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-107.85-95.99-89.06-32.61-53.41-11.85
Depreciation & Amortization
-4.07-4.09-0.850.180.250.51
Other Amortization
----0.02-
Loss (Gain) From Sale of Assets
----2.69-0.09
Asset Writedown & Restructuring Costs
----13.610.18
Loss (Gain) From Sale of Investments
0.050.050.810.89--
Stock-Based Compensation
15.1411.498.893.010.330.26
Other Operating Activities
-0.52.225.86514.27-
Change in Accounts Payable
-8.62-0.8710.610.480.57-0.29
Change in Other Net Operating Assets
-0.88-5-3.863.04-0.440.81
Operating Cash Flow
-106.73-92.18-67.6-23.71-34.81-10.29
Capital Expenditures
-0.15-0.06-0.06--0.1-0.13
Sale of Property, Plant & Equipment
---0.80.06-
Sale (Purchase) of Intangibles
----5--
Investment in Securities
-207.03-39.37-70.49---
Investing Cash Flow
-207.18-39.43-70.55-4.2-0.04-0.13
Short-Term Debt Issued
----5.6-
Long-Term Debt Issued
-24.7419.824.92--
Total Debt Issued
24.7424.7419.824.925.6-
Long-Term Debt Repaid
-----0.13-0.19
Net Debt Issued (Repaid)
24.7424.7419.824.925.47-0.19
Issuance of Common Stock
298.23116.0688.2151.730.230.05
Other Financing Activities
-17.87-7.26-6.1-2.77-0.41-
Financing Cash Flow
305.1133.54101.9353.8885.29-0.14
Net Cash Flow
-8.81.93-36.2225.9750.44-10.55
Free Cash Flow
-106.88-92.24-67.66-23.71-34.91-10.41
Free Cash Flow Per Share
-2.20-2.16-2.55-1.76-109.10-35.26
Cash Interest Paid
4.973.350.90.020.030.05
Levered Free Cash Flow
-74.73-62.13-42.37-20.38-29.09-
Unlevered Free Cash Flow
-71.1-59.76-41.75-20.37-29.01-
Change in Net Working Capital
8.743.35-7.08-2.94-1.28-
Source: S&P Capital IQ. Standard template. Financial Sources.